New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 3, 2014
08:35 EDTNPSPNPS Pharmaceuticals receives orphan drug designation for Natpara in Europe
NPS Pharmaceuticals announced that the European Commission has granted orphan drug designation to Natpara for the treatment of hypoparathyroidism. Orphan drug designation in the European Union is given to products that are designed for the diagnosis, prevention or treatment of rare diseases that are life-threatening or chronically debilitating. The company was also granted orphan drug status by the U.S. Food and Drug Administration in 2007. The company submitted its U.S. Biologic License Application to FDA in October 2013.
News For NPSP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 10, 2014
16:08 EDTNPSPNPS Pharmaceuticals sees FY14 OpEx $185M-$195M vs. prior view of $180M-$200M
Subscribe for More Information
16:07 EDTNPSPNPS Pharmaceuticals sees FY14 revenue at low end of $100M-$110M range
Subscribe for More Information
16:06 EDTNPSPNPS Pharmaceuticals reports Q3 EPS (2c), consensus 2c
Subscribe for More Information
15:26 EDTNPSPNotable companies reporting after market close
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use